Examples of using Recombinant factor in English and their translations into Dutch
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Recombinant factor VIIa(r-FVIIa) can also be considered.
It contains NS0-expressed recombinant GDF-8 and antibodies raised against the recombinant factor.
The recombinant factor IX portion is identical to the Thr148 allelic form of plasma- derived factor IX.
Coagulation factor concentrates(activated or non-activated) or recombinant Factor VIIa may be taken into account.
Recombinant Factor IX Parameters for Activity Data by Month in Previously Treated Patients.
and/or recombinant factor VIIa may increase haemostasis.
Re-dosing of recombinant factor VIIa shall be considered
administration of recombinant factor VIIa may be considered.
A 28% lower recovery of recombinant Factor IX in comparison to plasma derived Factor IX was shown.
have been observed with recombinant factor VIII products and may in some cases progress to severe anaphylaxis including shock.
Recombinant Factor IX Summary of Pharmacokinetic Parameters for Activity Data by Month in Previously Treated Patients.
Pharmacokinetic parameters of recombinant Factor IX have also been determined after single and.
In studies with recombinant factor VIII preparations, development of inhibitors is predominantly observed in previously untreated haemophiliacs.
The cleavable linker between the recombinant factor IX and albumin molecules is derived from the endogenous“activation peptide” in native factor IX.
Pharmacokinetic parameters of recombinant Factor IX have also been determined after single
The number of units of recombinant factor IX Fc administered is expressed in International Units(IU),
Structural differences of the recombinant Factor IX molecule compared with plasma derived Factor IX appear to contribute to the different recovery compared to plasma derived Factor IX.
The calculation of the required dose of recombinant factor VIII Fc is based on the empirical finding that 1 International Unit(IU)
Although Bayerand Ba: der had granted distribution licences for recombinant factor VIII to Armour,
in which the drug potency of ReFacto AF and a full-length recombinant factor VIII( FLrFVIII) comparator, and the FVIII activity measured in patient plasma samples were all determined using the same one-stage
The active substance is moroctocog alfa recombinant coagulation factor VIII.